Sees FY24 organic sales growth, excluding COVID-19 testing-related sales, in the range of 8.0%-10.0%. FY24 revenue consensus $41.71B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ABT:
- Options Volatility and Implied Earnings Moves Today, January 24, 2024
- Options Volatility and Implied Earnings Moves This Week, January 22 – January 26, 2024
- Abbott Laboratories (ABT) Q4 Earnings Cheat Sheet
- Abbott announces first procedures using its Volt Pulsed Field Ablation
- Abbott price target raised to $131 from $121 at Wells Fargo
